In order to gain insight into a possible modulatory role for ,u, 6, and c opioid receptors of the nigrostriatal dopaminergic pathway, we investigated the topographical organization of the receptors with respect to pre-and postsynaptic membranes. Dopaminergic terminals projecting from the substantia nigra to the corpus striatum were destroyed by unilateral injection of 6-hydroxydopamine into the substantia nigra. Quantitative receptor assays using highly specific radioligands were used to measure the density of striatal it, 6, and K receptors before and after denervation. Denervation caused a 34 ± 2% loss of striatal 1A receptors and a 32 ± 1% loss of striatal 6 receptors on the lesioned side of the brain; in contrast, c receptors did not change significantly in density. Quantitative in vitro autoradiography was used to visualize the neuroanatomical pattern of receptors on lesioned and nonlesioned sides of the brain under the light microscope. Loss of ,. receptors in striatal patches was striking in the ventrolateral areas of the striatum, whereas the most notable loss of 6 receptors was found in the central striatum. Other brain areas did not differ significantly in , 1 receptor density between the lesioned and nonlesioned sides, as determined by autoradiography. These findings suggest that a high percentage of ,u and 6 receptors in the striatum are located on the nigrostriatal dopaminergic terminals and support the concept of a modulatory role for ,u and 6 opioid peptides in the nigrostriatal dopaminergic pathway.
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Anatomical and functional relationships between the enkephalinergic and dopaminergic circuitry of the brain are well documented for the mesotelencephalic dopaminergic pathways (for reviews, see refs. 1 and 2) . Considerable evidence supports the concept that opioid peptides act at opioid receptor sites to modulate dopaminergic functions. For example, blockade of central opioid receptors by naloxone attenuates the locomotor activating properties of the indirect dopamine agonist amphetamine (3, 4) and its ability to lower brain stimulation-reward thresholds (5, 6) . Opioids stimulate dopamine release in vivo in the neostriatum (7) , increase the firing rate of nigrostriatal dopaminergic neurons (8) , and produce excitation of mescncephalic dopamine neurons (9) . Recently, the K-specific opioid peptide dynorphin and some K opioids have been shown to potently and selectively inhibit dopamine release from slices of rat striatum, whereas the 8-receptor agonist enkephalin [Leu5]Enk selectively inhibits acetylcholipe release (10) . This finding suggests that specificity is imparted to forebrain enkephalinergic-dopaminergic interactions by differential activation of specific opioidreceptor types or subtypes.
The specific locus of mesotelencephalic enkephalinergicdopaminergic interaction has received considerable research attention. Opioids may act directly at sites located on the dopaminergic cell bodies, on neurons constituting the feedback loops from the forebrain dopamine projection areas, or on dopaminergic terminals in the neostriatum. Preliminary studies have shown that destruction of the nigrostriatal dopaminergic system by 6-hydroxydopamine causes a partial loss of striatal opioid receptors, suggesting the presence of opioid receptors on dopaminergic terminals in this region (11) (12) (13) . These studies did not, however, identify specific opioid-receptor types.
The neostriatum contains a high concentration of enkephalinergic neurons (14) and high densities of At and 8 opioid receptors (15) (16) (17) . To gain insight into possible differential modulatory roles for the u, 8 , and K receptors of the neostriatum, we have investigated their topographical organization with respect to pre-and postsynaptic membranes.
The present study differs from previous studies of the effects of neurotoxins on opioid receptor losses in two important respects. (i) We used radioligands highly specific for the a, 8 , and K opioid receptors to determine the fraction of each receptor type lost in the neostriatum after 6-hydroxydopamine-or kainic acid-induced lesions.
(ii) Quantitative in vitro autoradiography at the level of the light microscope was used to visualize the neuroanatomical distribution of these receptors on both lesioned and nonlesioned sides of the brain. This method allows a precise localization of the lesion and also the calculation of the receptor loss in the area where neurons died.
METHODS
Dopamine Assays. Samples of striatal tissue from the right and left sides of lesioned and control rats were analyzed by reverse-phase HPLC using a C18 Vydac column eluted with 0.1 M chloroacetate, pH 3.2/1 mM EDTA/0.4 mM sodium octyl sulfate/8% MeOH at a flow rate of 1 ml/min. Dopamine concentration was determined by electrochemical detection and reference to a standard curve.
Opioid Receptor Binding Assays. Tissue preparation, protein assays, and radioligand binding were carried out as previously described (18 (17, 19) . Scatchard plots of the data were evaluated by computer-assisted linear regression analysis using the LIGAND program (20) .
Autoradiography. Autoradiographic studies were carried out using tritium-sensitive LKB film as described (17, 21, 22) . Lesioned and control animals were decapitated 15 days after microinjection of 6-hydroxydopamine or vehicle, respectively; brains were rapidly removed, and coronal sections (20 ,um) were prepared as described (23 (23) . The optical density of each structure was determined, and receptor density values were computed as described (17, 23 
RESULTS
Dopamine Determinations and Verification of Lesion Placement. Fifteen days after injection of 6-hydroxydopamine into the substantia nigra, the dopamine content of the striatum on the lesioned side of the brain was decreased 87% compared with the striatum of control animals; in sham-operated into the pars compacta of the left substantia nigra. The microliter syringe was lowered into the medial substantia nigra at coordinates; anteroposterior +2.8, mediolateral +1.6, and dorsoventral -3.5, according to the atlas of Pellegrino et al. (23) . SNC, substantia nigra pars compacta; SN, substantia nigra.
animals a 7% decrease in dopamine content was seen. Fig. 1 shows bright-field photomicrographs of thionine-formolstained coronal sections of lesioned rat brain at the level of the substantia nigra (15 days after 6-hydroxydopamine injection). A significant loss of cell bodies and nerve fibers in the substantia nigra was seen on the lesioned side relative to the nonlesioned side. After kainic acid injection into the caudateputamen, a significant loss of cell bodies, coupled with extensive and characteristic kainate-induced alterations in cell body morphology, was seen in the lesioned caudateputamen relative to the nonlesioned side four days after neurotoxin administration (data not shown).
Quantitative Receptor Measurements. Scatchard analysis of the equilibrium binding of [3H] [D-Ala2,N-MePhe4,Glyo15]Enk (it-specific ligand) to striatal membranes from the brains of control rats revealed a linear plot (Fig. 2a) . Computer-assisted linear regression analysis (20) Neurobiology: Eghbali et al. sides of 6-hydroxydopamine-lesioned brains. The means ± SEM of three independent determinations indicated a statistically significant loss of 34 ± 2% (P < 0.01) , receptors and 32 ± 1% (P < 0.01) 8 4 . Autoradiograms of selected coronal sections of rat brain at the level of the anterior commissure of (a) control and (b) 6-hydroxydopamine-injected rats. The procedures for receptor labeling and for autoradiography were as described. In the sections from 6-hydroxydopamine-injected rats (b), p. receptor density in the striatal patches is markedly decreased relative to that of the nonlesioned side or of control brain (a). The loss of ,u receptors is striking in the ventrolateral areas of the striatum. sections from control and lesioned rats were incubated with radiolabeled ligand on the same day in the same solutions and exposed to the same sheet of LKB film to enable comparison of brain sections. Autoradiograms of selected coronal sections at the level of the anterior commissure are shown in Fig.  4 . The labeling of , receptor in sections of control brains (Fig.  4a Left) showed dense patches of receptor labeling in the caudate-putamen overlying the "striosomes." This topographical organization is consonant with the previously reported pattern of ,u receptor labeling in the striatum (15) (16) (17) 21) . Dense , receptor labeling was also seen in a thin band along the lateral margins of the caudate-putamen and in the dorsomedial one-third of the nucleus accumbens. Less dense but still highly significant A receptor labeling was also seen in the anterior cingulate cortex, in both the superficial and deep layers of the medial frontoparietal cortex (approximately the agranular and medial motor areas), and in the endopiriform nucleus and adjacent claustrum.
In sections from 6-hydroxydopamine-lesioned rats, ,u receptor density in the striatal patches was markedly decreased relative to the nonlesioned side or control brain (Fig. 4b Left) . The loss of striatal , receptors in the patches was particularly striking in the ventrolateral areas of the striatum. Quantitative autoradiography receptor density determinations for ,u receptors in different brain regions (Table 2 ) revealed significant decreases (-43%) in u receptors in striatal patches in denervated striatum as compared to contralateral side (nondenervated) striatum, but no significant differences occurred between lesioned and nonlesioned sides of the brain for u receptor density in striatal surrounds, frontoparietal cortex, neocortex layer IV, nucleus accumbens, or hippocampus. Table 2 also shows that ,u receptor density was decreased to a lesser extent on the nondenervated side of 6-hydroxydopamine-lesioned brains relative to control brains for striatal patches, frontoparietal cortex, and nucleus accumbens.
Fig. 4 (DPDPE) depicts receptors labeled with [3H][D-
Pen2,D-Pen5]Enk in the telencephalon at the level of the anterior commissure. receptors were diffusely distributed throughout the striatum with markedly denser labeling in the ventrolateral regions, and noticeably dense labeling in the closely adjacent endopiriform nucleus and claustrum area. This topographical pattern is similar in control and lesioned rats, except that the density of 8 receptor labeling is markedly decreased in the central regions of the striatum on the lesioned side. Quantitative analysis of receptor densities of other brain structures revealed no significant changes in receptor density except for the nucleus accumbens; quantitative determinations for K receptor-labeled brain sections showed no significant 6-hydroxydopamine-induced receptor density changes (Table 2) .
DISCUSSION
The present study has used quantitative in vitro autoradiography together with selective neurotoxins to investigate the cellular localization of A, 8 , and K opioid receptors. Quantitative receptor assays involving homogenate samples provided data concerning specific opioid receptor loss due to 6-hydroxydopamine-induced destruction of dopaminergic terminals. Denervation caused a 34 ± 2% loss of u receptors and a 32 ± 1% loss of receptors in the striatum ipsilateral to the lesion; K receptors exhibited no significant change in density. Results of the kainic acid study, indicating a ,u receptor loss of -60% after destruction of cell bodies in the striatum, are consistent with the 6-hydroxydopamine experiments because kainic acid would be expected to destroy receptors localized on cell bodies, whereas 6-hydroxy- (ii) The afferent terminals that were destroyed do not release Enk and thus are unlikely to affect postsynaptic opioid receptor sites. Or receptor loss could be due to transsynaptic degeneration. However, this is probably not the sole mechanism underlying the observed loss of receptors because the time course for loss of striatal , and 8 receptors is well correlated with the time course for dopamine depletion in the striatum.
Why are there losses in receptor density on the nonlesioned side of the brain? Several explanations are possible. It is well known that intracranial injections of 6-hydroxydopamine often result in spread of the neurotoxin from the injection site. In this study, however, the finding of a mere 7% loss of dopamine in the striatum contralateral to the lesion makes that explanation unlikely. Other explanations include compensatory receptor changes on the contralateral side and nonspecific pathological changes from injection of the neurotoxin.
A recent autoradiographic study of opioid receptor localization using electron microscopic techniques has shown that 53% of opioid binding sites are associated with axo-dendritic interfaces, 18% with axo-axonic interfaces, and only 3% with axo-somatic interfaces (25) . A major difference between that study and this study is that our autoradiographic procedure does not involve fixing the tissue, a procedure that could result in redistribution of the radioligand.
The present study combines the use of selective neurotoxins, specific radioligands, and quantitative receptor autoradiography, which together allow for microscopic visualization of specific opioid receptor classes. Thus, the precise differential distribution of u and 8 receptors within the striatum could be anatomically delineated, as well as the differential anatomic gradients and localizations of receptor loss after selective dopaminergic denervation. This approach should have broad applicability to the measurement and localization of multiple receptor classes after brain lesions or in neurological-deficit states.
